- Home
- NAII vs AEON Comparison
NAII vs AEON Comparison
Compare NAII & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAII
- AEON
- Stock Information
- Founded
- NAII 1980
- AEON N/A
- Country
- NAII United States
- AEON United States
- Employees
- NAII N/A
- AEON N/A
- Industry
- NAII Medicinal Chemicals and Botanical Products
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- NAII Health Care
- AEON Health Care
- Exchange
- NAII Nasdaq
- AEON Nasdaq
- Market Cap
- NAII 26.0M
- AEON 21.6M
- IPO Year
- NAII 1987
- AEON N/A
- Fundamental
- Price
- NAII $4.05
- AEON $0.12
- Analyst Decision
- NAII
- AEON Strong Buy
- Analyst Count
- NAII 0
- AEON 1
- Target Price
- NAII N/A
- AEON $5.00
- AVG Volume (30 Days)
- NAII 4.9K
- AEON 6.9M
- Earning Date
- NAII 02-14-2025
- AEON 03-28-2025
- Dividend Yield
- NAII N/A
- AEON N/A
- EPS Growth
- NAII N/A
- AEON N/A
- EPS
- NAII N/A
- AEON 0.34
- Revenue
- NAII $121,853,000.00
- AEON N/A
- Revenue This Year
- NAII N/A
- AEON N/A
- Revenue Next Year
- NAII N/A
- AEON N/A
- P/E Ratio
- NAII N/A
- AEON $0.35
- Revenue Growth
- NAII N/A
- AEON N/A
- 52 Week Low
- NAII $4.02
- AEON $0.10
- 52 Week High
- NAII $7.26
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- NAII 36.48
- AEON 34.82
- Support Level
- NAII $4.08
- AEON $0.10
- Resistance Level
- NAII $4.19
- AEON $0.14
- Average True Range (ATR)
- NAII 0.11
- AEON 0.01
- MACD
- NAII -0.01
- AEON 0.01
- Stochastic Oscillator
- NAII 8.76
- AEON 46.76
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.